Back to top

Becton Dickinson announces STANCE clinical trial enrollment milestone

Becton Dickinson (BDX) announced a milestone in its advanced tissue regeneration strategy and expansion efforts with the STANCE clinical trial eval...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Becton, Dickinson and Company (BDX)

Box, Inc. (BOX)